VC  KBL Healthcare Ventures

     Office Locations:

52 East 72nd Street
New York, NY 10021
Phone: 212-319-5555
Fax: 212-319-5591



  • Early
  • Growth



  • Life Sciences & Healthcare
  • Medical Device



    KBL is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies. The firm's goal is to identify companies that are run by seasoned management teams and that have the potential to create long term value. Major areas of investment include life sciences, medical devices, healthcare services and medical information technology. Within the life sciences space, KBL will invest in biopharmaceuticals, drug discovery platforms and advanced materials. Within the medical device area, KBL seeks companies addressing large, unmet medical needs with demonstrated clinical benefit. In July 2007, KBL completed a $138 million IPO led by Citi to target a merger with a healthcare or healthcare-related business.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Eli Berk Vice President
    Marlene Krauss M.D. Managing Director and Chief Executive Officer
    Zachary Berk O.D. Managing Director and Chairman


    Portfolio companies include:

      Achillion Pharmaceuticals
        web link

      Avalon Pharmaceuticals
        web link

        web link

        web link

      Ista Pharmaceuticals
        web link

        web link

        web link

        web link

        web link

      Prolong Pharmaceuticals
        web link

      Remon Medical Technologies
        web link

      Scandius BioMedical
        web link

        web link

      Spinal Concepts
        web link


    Recent News: